Efficient detection of eukaryotic calcium-sensing receptor
In direction of middle-up evaluation of polyclonal antibodies: subclass-specific N-glycosylation profiling of murine immunoglobulin G (IgG) by the use of HPLC-MS
- Lately, superior HPLC-MS methods based mostly on intact protein (“top-down”) or protein subunit (“middle-up/middle-down”) evaluation have been applied for the characterization of therapeutic monoclonal antibodies. Right here, we assess feasibility of middle-up/middle-down evaluation for polyclonal IgGs exhibiting in depth sequence variability. Particularly, we addressed IgGs from mouse, representing an essential mannequin system in immunological investigations.
- To acquire Fc/2 parts as conserved subunits of IgGs, we made use of the bacterial protease SpeB. For this function, we initially decided SpeB cleavage websites in murine IgGs. The ensuing Fc/2 parts attribute of various subclasses had been subsequently analysed by ion-pair reversed-phase HPLC hyphenated to high-resolution mass spectrometry. This enabled simultaneous relative quantification of IgG subclasses and their N-glycosylation variants, each of which affect IgG effector features.
- To evaluate methodology capabilities in an immunological context, we utilized the analytical workflow to polyclonal antibodies obtained from BALB/c mice immunized with the grass pollen allergen Phl p 6. The research revealed a shift in IgG subclasses and Fc-glycosylation patterns in whole and antigen-specific IgGs from totally different mouse cohorts, respectively. Finally, Fc/2 characterization might reveal different protein modifications together with oxidation, amino acid exchanges, and C-terminal lysine, and will thus be applied for high quality management of practical antibodies.
Environment friendly detection of eukaryotic calcium-sensing receptor (CaSR) by polyclonal antibody towards prokaryotic expressed truncated CaSR
Calcium-sensing receptor (CaSR), which is best identified for its motion as regulating calcium homeostasis, can bind varied ligands. To facilitate analysis on CaSR and perceive the receptor’s operate additional, an in silico designed truncated protein was developed. The ensuing protein folding indicated that 99% of predicted three dimensional (3D) construction residues are positioned in favored and allowed Ramachandran plots. Nonetheless, it was discovered that such protein doesn’t fold correctly when expressed in prokaryotic host cells.
Thioredoxin (Trx) tag was conjugated to extend the ultimate protein’s solubility, which may assist acquire the soluble antigen with higher immunogenic properties. The truncated recombinant proteins had been expressed and purified in two kinds (Trx-CaSR: RR19 and CaSR: RRJ19). The polyclonal antibody was induced by the rabbit immunization with the type of RR19. Western blot on mouse kidney lysates evidenced the correct immune recognition of the receptor by the produced antibody.
The specificity and sensitivity of antibodies had been additionally assayed by immunohistofluorescence. These experiments affirmed antibody’s means to point the receptor on the cell floor in native type and the potential for making use of such antibodies in additional mobile and tissue assays.
Doxorubicin Hydrochloride |
|||
40410004-1 | Glycomatrix | 10 mg | EUR 136.34 |
Doxorubicin Hydrochloride |
|||
40410004-2 | Glycomatrix | 25 mg | EUR 273.17 |
Doxorubicin Hydrochloride |
|||
D558000 | Toronto Research Chemicals | 100mg | EUR 136 |
Description: 25316-40-9 |
Doxorubicin hydrochloride |
|||
GA4969-100MG | Glentham Life Sciences | 100 mg | EUR 217.2 |
Doxorubicin hydrochloride |
|||
GA4969-10MG | Glentham Life Sciences | 10 mg | EUR 93.6 |
Doxorubicin hydrochloride |
|||
GA4969-25MG | Glentham Life Sciences | 25 mg | EUR 117.6 |
Doxorubicin hydrochloride |
|||
GA4969-50MG | Glentham Life Sciences | 50 mg | EUR 151.2 |
Doxorubicin hydrochloride |
|||
ADC-P-014 | Creative Biolabs | unit | Ask for price |
Doxorubicin Hydrochloride |
|||
20-abx076623 | Abbexa |
|
|
Doxorubicin hydrochloride |
|||
TNC00267 | ChemNorm | 20mg | Ask for price |
Doxorubicin (hydrochloride) |
|||
HY-15142 | MedChemExpress | 100mg | EUR 176.4 |
Doxorubicin Hydrochloride |
|||
SIH-390-10MG | Stressmarq | 10 mg | EUR 129 |
Description: Apoptosis Inducer |
Doxorubicin Hydrochloride |
|||
SIH-390-50MG | Stressmarq | 50 mg | EUR 465 |
Description: Apoptosis Inducer |
Doxorubicin hydrochloride |
|||
T1020-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride, 98% |
|||
GP9056-100 | Glentham Life Sciences | 100 | EUR 140.2 |
Doxorubicin hydrochloride, 98% |
|||
GP9056-25 | Glentham Life Sciences | 25 | EUR 56.1 |
Doxorubicin hydrochloride USP |
|||
D005-10MG | TOKU-E | 10 mg | EUR 117.34 |
Description: C27H29NO11•HCl |
Doxorubicin hydrochloride USP |
|||
D005-25MG | TOKU-E | 25 mg | EUR 234.67 |
Description: C27H29NO11•HCl |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-10 | Glentham Life Sciences | 10 | EUR 47.4 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-100 | Glentham Life Sciences | 100 | EUR 150.4 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-25 | Glentham Life Sciences | 25 | EUR 67.2 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-50 | Glentham Life Sciences | 50 | EUR 95 |
Doxorubicin-hydrazone-caproyl-maleimide Hydrochloride (~80%) |
|||
D399610 | Toronto Research Chemicals | 250mg | EUR 150 |
Doxorubicinol hydrochloride |
|||
T40736-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol Hydrochloride (>90%) (Mixture of diastereomers) |
|||
D558020 | Toronto Research Chemicals | 10mg | EUR 141 |
Hydroxyacetyl Doxorubicin |
|||
H415946 | Toronto Research Chemicals | 25mg | EUR 15000 |
Doxorubicin |
|||
D063-100MG | TOKU-E | 100 mg | EUR 1261.2 |
Doxorubicin |
|||
D063-25MG | TOKU-E | 25 mg | EUR 131.79 |
Description: C27H29NO11 |
Doxorubicin |
|||
D063-5MG | TOKU-E | 5 mg | EUR 460.82 |
Description: C27H29NO11 |
Doxorubicin |
|||
ADC-P-013 | Creative Biolabs | unit | Ask for price |
Doxorubicin |
|||
A3966-10 | ApexBio | 10 mg | EUR 48 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
A3966-100 | ApexBio | 100 mg | EUR 154 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
A3966-25 | ApexBio | 25 mg | EUR 67 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
A3966-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
A3966-S | ApexBio | Evaluation Sample | EUR 22 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
abx188695-1g | Abbexa | 1 g | EUR 560.4 |
Doxorubicin |
|||
T1456-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
HY-15142A | MedChemExpress | 100mg | EUR 258 |
Doxorubicin HCl |
|||
20-abx184016 | Abbexa |
|
|
Doxorubicin HCl |
|||
abx076623-25ml | Abbexa | 25 ml | EUR 187.5 |
Doxorubicin HCl |
|||
abx076623-5ml | Abbexa | 5 ml | EUR 118.75 |
Doxorubicin 10mM |
|||
TG4120 | TopoGen | 0.25ml | EUR 187.2 |
Doxorubicin-SMCC |
|||
406622 | MedKoo Biosciences | 1.0mg | EUR 90 |
Doxorubicin-MVCP |
|||
T31567-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-SMCC |
|||
T15161-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin HCl, 100mg |
|||
R2531 | ACTGene | 100mg | EUR 1080.79 |
Doxorubicin HCl, 100mg |
|||
R2531-100mg | ACTGene | each | EUR 1560 |
Doxorubicin HCl, 10mg |
|||
R2531-10mg | ACTGene | each | EUR 236.4 |
Adriamycin (Doxorubicin) |
|||
E1KS1208 | EnoGene | 10mg | EUR 276 |
Doxorubicin Free Base |
|||
100960 | MedKoo Biosciences | 10.0mg | EUR 150 |
Doxorubicin (Adriamycin) HCl |
|||
A1832-10 | ApexBio | 10 mg | EUR 36 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-100 | ApexBio | 100 mg | EUR 128 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-25 | ApexBio | 25 mg | EUR 52 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: Antitumour antibiotic,inhibits TOPO II. |
4'O-Benzyl Doxorubicin |
|||
B788120 | Toronto Research Chemicals | 100mg | EUR 1200 |
Description: 677017-23-1 |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-1g | TargetMol Chemicals | 1g | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
7-Deoxy Doxorubicin Aglycone (> 75%) |
|||
D232910 | Toronto Research Chemicals | 10mg | EUR 299 |
Description: 38554-25-5 |
PEGylated Liposomal Doxorubicin- 2 mg |
|||
PHPC002DX | ProFoldin | 2 mg | EUR 140.62 |
Description: This product includes 1 ml of liposomal doxorubicin at concentrations of 2 mg/ml doxorubicin and 16 mg/ml of lipids. |
PEGylated Liposomal Doxorubicin- 20 mg |
|||
PHPC020DX | ProFoldin | 20 mg | EUR 358.62 |
Description: This product includes 10 ml of liposomal doxorubicin at concentrations of 2 mg/ml doxorubicin and 16 mg/ml of lipids. |
Doxorubicin-hydrazone-caproyl-maleimide |
|||
D558040 | Toronto Research Chemicals | 100mg | EUR 1800 |
Description: 151038-96-9 |
Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
|||
IHUHELADTLW500UG | Innovative research | each | EUR 327 |
Description: Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
|||
IHUHELADTLN200UG | Innovative research | each | EUR 427 |
Description: Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
7,8-Desacetyl-9,10-dehydro Daunorubicinone (~90%)(Doxorubicin Impurity) |
|||
D288680 | Toronto Research Chemicals | 10mg | EUR 4281 |
Description: 1159977-24-8 |
Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate - Doxorubicin Stimulated |
|||
HCL-2010 | Alpha Diagnostics | 100ug | EUR 255.6 |
6,8,11-Trihydroxy-1-methoxy-5,12-naphthacenedione (Doxorubicin Impurity) |
|||
T795210 | Toronto Research Chemicals | 10mg | EUR 244 |
Description: 64845-67-6 |
Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract - Doxorubicin Stimulated |
|||
HCL-2004 | Alpha Diagnostics | 100ug | EUR 270 |
Des-[(4-Amino-2,3,6-trideoxy-hexapyranosyl)oxy)-1-methyl] 2-Carboxylate Doxorubicin |
|||
D558001 | Toronto Research Chemicals | 100mg | EUR 4500 |
Doxorubicin.HCl |
|||
1527-5 | Biovision | each | EUR 183.6 |
Doxorubicinol (>90%) |
|||
D558025 | Toronto Research Chemicals | 2.5mg | EUR 1929 |
Doxorubicinol |
|||
T25349-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinone |
|||
D559070 | Toronto Research Chemicals | 25mg | EUR 244 |
Description: 24385-10-2 |
Doxorubicinone |
|||
T29673-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicinone |
Doxorubicinone |
|||
T29673-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicinone |
Doxorubicinone |
|||
T29673-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicinone |
Doxorubicinone |
|||
T29673-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicinone |
Doxorubicinone |
|||
T29673-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicinone |
APY29 Hydrochloride Salt |
|||
A735422 | Toronto Research Chemicals | 100mg | EUR 224 |
3-N-Carboxylic Acid 1-beta-D-Glucuronide-[4-(methyl)phenyl]carbamate Ester Doxorubicin |
|||
C177855 | Toronto Research Chemicals | 50mg | EUR 11200 |
Description: 211364-63-5 |
Axomadol Hydrochloride Salt |
|||
A583490 | Toronto Research Chemicals | 100mg | EUR 11200 |
Description: 187219-95-0 |
Morphine Hydrochloride Salt |
|||
M652280 | Toronto Research Chemicals | 100mg | EUR 500 |
Description: 52-26-6 |
OPC 4392 Hydrochloride Salt |
|||
O667500 | Toronto Research Chemicals | 100mg | EUR 193 |
Erlotinib, Hydrochloride Salt |
|||
1588-100 | Biovision | each | EUR 202.8 |
Erlotinib, Hydrochloride Salt |
|||
1588-1000 | Biovision | each | EUR 477.6 |
Carazolol Hydrochloride Salt |
|||
C175810 | Toronto Research Chemicals | 100mg | EUR 138 |
Description: 51997-43-4 |
Carazolol hydrochloride salt |
|||
574509 | MedKoo Biosciences | 50.0mg | EUR 285 |
Tofenacin Hydrochloride Salt |
|||
T528500 | Toronto Research Chemicals | 10mg | EUR 339 |
Osutidine Hydrochloride Salt |
|||
O703910 | Toronto Research Chemicals | 100mg | EUR 1696 |
CHIR 99021 Hydrochloride Salt |
|||
C292157 | Toronto Research Chemicals | 100mg | EUR 178 |
Difloxacin Hydrochloride Salt |
|||
D445600 | Toronto Research Chemicals | 100mg | EUR 460 |
Description: 91296-86-5 |
Dimethacrine Hydrochloride Salt |
|||
D460270 | Toronto Research Chemicals | 100mg | EUR 4500 |
Description: 100000-17-7 |
Ramifenazone Hydrochloride Salt |
|||
R110500 | Toronto Research Chemicals | 100mg | EUR 86 |
Description: 18342-39-7 |
Pexidartinib Hydrochloride Salt |
|||
P293640 | Toronto Research Chemicals | 100mg | EUR 800 |
Description: 2040295-03-0 |
Volinanserin Hydrochloride Salt |
|||
V755000 | Toronto Research Chemicals | 1mg | EUR 598 |
Lysinoalanine Hydrochloride Salt |
|||
L488650 | Toronto Research Chemicals | 10mg | EUR 219 |
Description: 93113-28-1 |
7,8,9,10-Dehydro Doxorubicinone (~70%) |
|||
D229580 | Toronto Research Chemicals | 10mg | EUR 5528 |
Description: 1159977-23-7 |
Aposcopolamine Hydrochloride Salt |
|||
A729005 | Toronto Research Chemicals | 100mg | EUR 230 |
Description: 890416-03-2 |
I-CBP 112 Hydrochloride Salt |
|||
I163880 | Toronto Research Chemicals | 5mg | EUR 403 |
Description: 2147701-33-3 |
Bleomycin A5 Hydrochloride Salt |
|||
B595750 | Toronto Research Chemicals | 10mg | EUR 230 |
Description: 55658-47-4 |
Erlotinib, Hydrochloride Salt, >99% |
|||
BC026-101 | GenDepot | 1g | EUR 327.6 |
Erlotinib, Hydrochloride Salt, >99% |
|||
BC026-102 | GenDepot | 2g | EUR 465.6 |
Erlotinib, Hydrochloride Salt, >99% |
|||
BC026-105 | GenDepot | 5g | EUR 684 |
Dopamine -13C8 Hydrochloride Salt |
|||
D533784 | Toronto Research Chemicals | 25mg | EUR 7600 |
Peramine Hydrochloride Salt-d3 |
|||
P285302 | Toronto Research Chemicals | 10mg | EUR 184 |
Bromo Didehydro Doxorubicinone |
|||
B682880 | Toronto Research Chemicals | 25mg | EUR 1200 |
Description: 63626-06-2 |
Carazolol-d6, Hydrochloride Salt |
|||
C175812 | Toronto Research Chemicals | 50mg | EUR 181 |
Description: 1184973-07-6 |
Tofenacin Hydrochloride Salt-d4 |
|||
T528502 | Toronto Research Chemicals | 10mg | EUR 190 |
17-DMAG, Hydrochloride Salt, >98% |
|||
BC024-001 | GenDepot | 1mg | EUR 213.6 |
17-DMAG, Hydrochloride Salt, >98% |
|||
BC024-005 | GenDepot | 5mg | EUR 343.2 |
17-DMAG, Hydrochloride Salt, >98% |
|||
BC024-010 | GenDepot | 10mg | EUR 489.6 |
17-DMAG, Hydrochloride Salt, >98% |
|||
BC024-025 | GenDepot | 25mg | Ask for price |
17-DMAG, Hydrochloride Salt, >99% |
|||
BC024-100 | GenDepot | 100mg | Ask for price |
17-DMAG, Hydrochloride Salt, >99% |
|||
BC024-101 | GenDepot | 1g | Ask for price |
17-DMAG, Hydrochloride Salt, >99% |
|||
BC024-250 | GenDepot | 250mg | Ask for price |
Flupirtine-d4 Hydrochloride Salt |
|||
F598512 | Toronto Research Chemicals | 10mg | EUR 215 |
Description: 1324717-75-0 |
Difloxacin-d3 Hydrochloride Salt |
|||
D445601 | Toronto Research Chemicals | 10mg | EUR 127 |
Description: 1173021-89-0 |
rac-Emixustat Hydrochloride Salt |
|||
B224873 | Toronto Research Chemicals | 1g | EUR 3000 |
Description: 1222169-23-4 |
Abeprazan dimer Hydrochloride salt |
|||
A642330 | Toronto Research Chemicals | 100mg | EUR 17000 |
cis-Mefentanyl Hydrochloride Salt |
|||
M205505 | Toronto Research Chemicals | 50mg | EUR 232 |
Description: 78995-18-3 |
rac Metanephrine Hydrochloride Salt |
|||
M258760 | Toronto Research Chemicals | 100mg | EUR 207 |
Description: 881-95-8 |
b-Isothipendyl Hydrochloride Salt |
|||
I902751 | Toronto Research Chemicals | 100mg | EUR 845 |
Description: 132962-42-6 |
Ondansetron-d3 Hydrochloride Salt |
|||
O655002 | Toronto Research Chemicals | 10mg | EUR 193 |
Description: 1346605-02-4 |
OSU-03012, Hydrochloride Salt, >98% |
|||
BC061-005 | GenDepot | 5mg | EUR 375.6 |
OSU-03012, Hydrochloride Salt, >98% |
|||
BC061-025 | GenDepot | 25mg | EUR 634.8 |
MEL3 Isomer I Hydrochloride Salt |
|||
M155671 | Toronto Research Chemicals | 50mg | EUR 15000 |
MEL3 Isomer II Hydrochloride Salt |
|||
M155672 | Toronto Research Chemicals | 50mg | EUR 7600 |
Dimethacrine Hydrochloride Salt-d3 |
|||
D460272 | Toronto Research Chemicals | 100mg | EUR 9200 |
Linear Daptomycin Hydrochloride Salt |
|||
L466475 | Toronto Research Chemicals | 2.5mg | EUR 269 |
Iso Desloratadine Hydrochloride Salt |
|||
I815005 | Toronto Research Chemicals | 10mg | EUR 1185 |
Volinanserin-d4 Hydrochloride Salt |
|||
V755002 | Toronto Research Chemicals | 10mg | EUR 265 |
Description: 1217617-73-6 |
2'-Nor Thiamine Hydrochloride Salt |
|||
N830500 | Toronto Research Chemicals | 100mg | EUR 249 |
Description: 49614-72-4 |
Tamsulosin Diether Hydrochloride Salt |
|||
E736620 | Toronto Research Chemicals | 100mg | EUR 695 |
Apovincaminic Acid Hydrochloride Salt |
|||
A729250 | Toronto Research Chemicals | 500mg | EUR 193 |
Description: 72296-47-0 |
Keto-Isoxsuprine Hydrochloride Salt |
|||
K606400 | Toronto Research Chemicals | 100mg | EUR 1200 |
Synephrine-13C2,15N Hydrochloride Salt |
|||
S920002 | Toronto Research Chemicals | 0.1mg | EUR 1722 |
Description: 1329499-30-0 |
Apovincaminic acid hydrochloride salt |
|||
T37406-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Apovincaminic acid hydrochloride salt |
Apovincaminic acid hydrochloride salt |
|||
T37406-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Apovincaminic acid hydrochloride salt |
Apovincaminic acid hydrochloride salt |
|||
T37406-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Apovincaminic acid hydrochloride salt |
Apovincaminic acid hydrochloride salt |
|||
T37406-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Apovincaminic acid hydrochloride salt |
Apovincaminic acid hydrochloride salt |
|||
T37406-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Apovincaminic acid hydrochloride salt |
Reticuline Hydrochloride Salt (>90% ee) |
|||
R188500 | Toronto Research Chemicals | 0.5mg | EUR 2070 |
Description: 903-91-3 |
(R)-Norphenylephrine Hydrochloride Salt |
|||
N825510 | Toronto Research Chemicals | 25mg | EUR 3000 |
Description: 636-87-3 |
Dehydroxy Mirabegron Hydrochloride Salt |
|||
D230170 | Toronto Research Chemicals | 250mg | EUR 201 |
Description: 1581284-79-8 |
5-Nitroisoindoline Hydrochloride Salt |
|||
N496370 | Toronto Research Chemicals | 1g | EUR 75 |
Description: 400727-69-7 |
Azetidin-3-ol Hydrochloride Salt |
|||
A813200 | Toronto Research Chemicals | 25g | EUR 357 |
Description: 18621-18-6 |
Validamycin A (>70%) Hydrochloride Salt |
|||
V943430 | Toronto Research Chemicals | 100mg | EUR 322 |
CJ-023423 Hydrochloride Salt, Hydrate |
|||
C535808 | Toronto Research Chemicals | 1mg | EUR 2110 |
Desmethyl Sibutramine, Hydrochloride Salt |
|||
D292170 | Toronto Research Chemicals | 10mg | EUR 221 |
Description: 84467-94-7 |
Inhibitory Potential of Polyclonal Camel Antibodies towards New Delhi Metallo-β-lactamase-1 (NDM-1)
New Delhi Metallo-β-lactamase-1 (NDM-1) is probably the most prevalent kind of metallo-β-lactamase, in a position to hydrolyze virtually all antibiotics of the β-lactam group, resulting in multidrug-resistant micro organism. Up to now, there aren’t any clinically related inhibitors to combat NDM-1. Using dromedary polyclonal antibody inhibitors towards NDM-1 represents a promising new class of molecules with inhibitory exercise.
Within the present research, immunoreactivities of dromedary Immunoglobulin G (IgG) isotypes containing heavy-chain and standard antibodies had been examined after profitable immunization of dromedary utilizing growing quantities of the recombinant NDM-1 enzyme. Inhibition kinetic assays, carried out utilizing a spectrophotometric methodology with nitrocefin as a reporter substrate, demonstrated that IgG1, IgG2, and IgG3 had been in a position to inhibit not solely the hydrolytic exercise of NDM-1 but in addition Verona integron-encoded metallo-β-lactamase (VIM-1) (subclass B1) and L1 metallo-β-lactamase (L1) (subclass B3) with inhibitory focus (IC50) values starting from 100 to 0.04 μM.
Investigations on the flexibility of IgG subclasses to cut back the expansion of recombinant Escherichia coli BL21(DE3)/codon plus cells containing the recombinant plasmid expressing NDM-1, L1, or VIM-1 confirmed that the addition of IgGs (four and eight mg/L) to the cell tradition was unable to revive the susceptibility of carbapenems.
Apparently, IgGs had been in a position to work together with NDM-1, L1, and VIM-1 when examined on the periplasm extract of every cultured pressure. The inhibitory focus was within the micromolar vary for all β-lactams examined. A visualization of the 3D structural foundation utilizing the three enzyme Protein Knowledge Financial institution (PDB) recordsdata helps preliminarily the recorded inhibition of the three MBLs.
A Easy and Environment friendly Genetic Immunization Protocol for the Manufacturing of Extremely Particular Polyclonal and Monoclonal Antibodies towards the Native Type of Mammalian Proteins
We’ve got generated polyclonal and monoclonal antibodies by genetic immunization over the past twenty years. On this paper, we current our most profitable methodology acquired over these years and current the animals by which we obtained the very best charges of success. The method introduced is handy, simple, inexpensive, and generates antibodies towards mammalian proteins of their native type.
This protocol requires neither costly gear, resembling a gene gun, nor subtle methods such because the conjugation of gold microspheres, electroporation, or surgical procedure to inject in lymph nodes. The protocol introduced makes use of merely the purified plasmid expressing the protein of curiosity below a powerful promoter, which is injected at intramuscular and intradermal websites.
This method was examined in 5 species. Guinea pigs had been the animals of alternative for the manufacturing of polyclonal antibodies. Monoclonal antibodies could possibly be generated in mice by giving, as a final injection, a suspension of transfected cells. The antibodies detected their antigens of their native kinds. They had been extremely particular with very low non-specific background ranges, as assessed by immune-blots, immunocytochemistry, immunohistochemistry and circulation cytometry. We current herein an in depth and easy process to efficiently elevate particular antibodies towards native proteins.
Manufacturing of a polyclonal antibody towards inosine-uridine preferring nucleoside hydrolase of Acanthamoeba castellanii and its entry to prognosis of Acanthamoeba keratitis
Acanthamoeba keratitis (AK) is a uncommon illness however its prevalence all through the globe continues to develop, primarily as a result of elevated contact lens utilization. Since early-stage signs related to AK carefully resemble these from different corneal infections, correct prognosis is tough and this typically leads to delayed therapy and exacerbation of the illness, which might result in everlasting visible impairment. Accordingly, creating a speedy Acanthamoeba-specific diagnostic methodology is very desired.
Within the current research, a speedy and . Among the many huge portions of proteins secreted by the pathogenic Acanthamoeba, an open studying body of the inosine-uridine preferring nucleoside hyddifferential methodology for AK prognosis was developed utilizing the secretory proteins derived from the pathogenic Acanthamoebarolase (IPNH) gene was obtained. After expressing and purifying the IPNH protein utilizing the pGEX 4T-Three vector system, mice had been immunized with the purified proteins for polyclonal antibody technology.
Western blot was carried out utilizing protein lysates of the human corneal cell, non-pathogenic amoeba, pathogenic amoeba, and scientific amoeba isolate together with lysates from different causes of keratitis resembling Staphylococcus aureus, Pseudomonas aeruginosa, and Fusarium solani to verify Acanthamoeba-specificity.
Western blot utilizing the polyclonal IPNH antibody revealed that IPNH was Acanthamoeba-specific since these proteins had been solely noticed in lysates of Acanthamoeba origin or its tradition media. Our findings point out that the IPNH antibody of Acanthamoeba might function a possible agent for speedy and differential AK prognosis.
RIPA Lysis Buffer (Strong) |
|||
HY-K1001 | MedChemExpress | 100 mL | EUR 176.4 |
Carbol Fuchsin (ZN,Strong) |
|||
S005-125ML | EWC Diagnostics | 1 unit | EUR 3.16 |
Description: Carbol Fuchsin (ZN,Strong) |
Carbol Fuchsin (ZN,Strong) |
|||
S005-500ML | EWC Diagnostics | 1 unit | EUR 10.92 |
Description: Carbol Fuchsin (ZN,Strong) |
RIPA Lysis Buffer (Strong) |
|||
abx090624-100l | Abbexa | 100 µl | EUR 150 |
RIPA Lysis Buffer (Strong) |
|||
abx090624-1ml | Abbexa | 1 ml | Ask for price |
RIPA Lysis Buffer (Strong) |
|||
abx090624-200l | Abbexa | 200 µl | Ask for price |
Strong RIPA Lysis Buffer |
|||
EZPS03-1 | Shanghai WSHT Biotechnology | 100mL | EUR 15 |
WB Stripping Solution Strong |
|||
05677-65 | NACALAI TESQUE | 500ML | EUR 142.8 |
HiDecal (Strong decalcifying solution) |
|||
R085-500ML | EWC Diagnostics | 1 unit | EUR 21.95 |
Description: HiDecal (Strong decalcifying solution) |
Arg-SEC Mobile Phase(Strong) |
|||
17000-51 | NACALAI TESQUE | 1L | EUR 105 |
Pierce Seal Strong Roll - 1ROLL |
|||
PCR0636 | Scientific Laboratory Supplies | 1ROLL | EUR 1314.9 |
Pierce Seal Strong Sheets - PK100 |
|||
PCR0632 | Scientific Laboratory Supplies | PK100 | EUR 140.4 |
replacement tip Kit strong thick |
|||
INS2090 | Scientific Laboratory Supplies | EACH | EUR 8.33 |
Modified Duncan Strong (DS) Medium |
|||
M1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) Medium |
Pierce Seal Strong Roll610mX78mm - 1ROLL |
|||
PCR0628 | Scientific Laboratory Supplies | 1ROLL | EUR 1104.3 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-100mL | Shanghai WSHT Biotechnology | 100mL | EUR 9.6 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-500mL | Shanghai WSHT Biotechnology | 500mL | EUR 28.8 |
Tweezers Fine Strong CF Tips - EACH |
|||
INS5058 | Scientific Laboratory Supplies | EACH | EUR 37.6 |
Tweezers Flat Strong CF Tips - EACH |
|||
INS5100 | Scientific Laboratory Supplies | EACH | EUR 43.92 |
PCR Foil Seal Strong Sheets - PK100 |
|||
PCR0528 | Scientific Laboratory Supplies | PK100 | EUR 211.95 |
EP Reagent Sodium Hypochlorite Sol. Strong - 500ML |
|||
10816005 | Scientific Laboratory Supplies | 500ML | EUR 136.35 |
Pierce Seal Strong Sample Roll - 1ROLL |
|||
PCR0630 | Scientific Laboratory Supplies | 1ROLL | EUR 59.63 |
replacement tip Kit strong thick - EACH |
|||
INS2058 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
replacement tip Kit strong point - EACH |
|||
INS2094 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
Modified Duncan Strong (DS) HiVeg Medium |
|||
MV1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) HiVeg Medium |
Strong RIPA Lysis Buffer (without inhibitors) |
|||
EZPS03-2 | Shanghai WSHT Biotechnology | 100mL | EUR 12.6 |
EP Reagent Sodium Hydroxide Sol. Strong - 1L |
|||
1081404 | Scientific Laboratory Supplies | 1L | EUR 191.7 |
Tweezers, Rubis Sturdy, Strong Pointed, 115mm, 4.5€ |
|||
25046-1 | Polysciences Europe GmbH | 1EA | EUR 48 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-25 | Polysciences Europe GmbH | 25g | EUR 431 |
Description: 9015-51-4 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-5 | Polysciences Europe GmbH | 5g | EUR 113 |
Description: 9015-51-4 |
Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
|||
M-R-1013161 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
|||
M-R-1015229 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-1 | Polysciences Europe GmbH | 1000ml | EUR 192 |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-250 | Polysciences Europe GmbH | 250ml | EUR 62 |
A510, Type 2 Macroporous Strong Base Rsin, Chloride Form |
|||
50223-1 | Polysciences Europe GmbH | 1000ml | EUR 144 |
Description: 69011-15-0 |
DiagAg™ Strong Anion Exchange Agarose Particles, 40 μm |
|||
DAG-CL23-08 | Creative Diagnostics | 25 mL | EUR 1150 |
A510, Type 2 Macroporous Strong Base Resin, Chloride Form |
|||
50223-250 | Polysciences Europe GmbH | 250ml | EUR 47 |
Description: 69011-15-0 |
Genistin |
|||
1535-10 | Biovision | each | EUR 196.8 |
Genistin |
|||
G350020 | Toronto Research Chemicals | 10mg | EUR 63 |
Description: 529-59-9 |
Genistin |
|||
GC2802-10 | Glentham Life Sciences | 10 | EUR 242.4 |
Genistin |
|||
GC2802-100 | Glentham Life Sciences | 100 | EUR 960.1 |
Genistin |
|||
GC2802-25 | Glentham Life Sciences | 25 | EUR 382.3 |
Genistin |
|||
GC2802-250 | Glentham Life Sciences | 250 | EUR 1845.7 |
Genistin |
|||
GC2802-50 | Glentham Life Sciences | 50 | EUR 577.8 |
Genistin |
|||
540154 | MedKoo Biosciences | 500.0mg | EUR 450 |
Genistin |
|||
T2882-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Genistin |
Genistin |
|||
T2882-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Genistin |
Genistin |
|||
T2882-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Genistin |
Genistin |
|||
T2882-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Genistin |
Genistin |
|||
T2882-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Genistin |
Genistin |
|||
TB0370-1000 | ChemNorm | 4X20mg | EUR 321.6 |
Genistin |
|||
HY-N0595 | MedChemExpress | 50mg | EUR 170.4 |
Genistin |
|||
N1860-20 | ApexBio | 20 mg | EUR 100 |
Description: TdT inhibitor |
Genistin |
|||
abx282781-100g | Abbexa | 100 µg | Ask for price |
Genistin |
|||
abx282781-20g | Abbexa | 20 µg | EUR 106.25 |
Genistin |
|||
abx282781-50g | Abbexa | 50 µg | EUR 250 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-1 | Polysciences Europe GmbH | 1000ml | EUR 144 |
Description: 9052-45-3 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-250 | Polysciences Europe GmbH | 250ml | EUR 47 |
Description: 9052-45-3 |
Genistin, >99% |
|||
BC034-025 | GenDepot | 25mg | EUR 278.4 |
Genistin, >99% |
|||
BC034-050 | GenDepot | 50mg | EUR 327.6 |
Genistin, >99% |
|||
BC034-100 | GenDepot | 100mg | EUR 537.6 |
Genistin(Genistoside) |
|||
E1KS2301 | EnoGene | 25mg | EUR 211.2 |
Genistin malonate |
|||
TB0588-0005 | ChemNorm | 10mg | EUR 886.8 |
Optically clear sealing film for qPCR, Strong Bond, for PP plates, 100/pk |
|||
MS1000-PCR2 | Benchmark Scientific | 1 each | EUR 149.35 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 24-45 µm |
|||
DAG-YS23-27 | Creative Diagnostics | 25 mL | EUR 850 |
Genistin 6''-O-Acetate |
|||
G350030 | Toronto Research Chemicals | 100mg | EUR 7600 |
Description: 73566-30-0 |
Genistin 6''-O-Malonate |
|||
G350035 | Toronto Research Chemicals | 250mg | EUR 11200 |
Description: 51011-05-3 |
Foil seals, strong bonding for cold storage (-200 to 110°C) and DMSO, for PP plates, 100/pk |
|||
MS1000-F2 | Benchmark Scientific | 1 each | EUR 149.35 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, Low Capacity |
|||
DAG-YS23-28 | Creative Diagnostics | 25 mL | EUR 850 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, High Capacity |
|||
DAG-YS23-29 | Creative Diagnostics | 25 mL | EUR 850 |
Rat Strongyloid IgG |
|||
QY-E11978 | Qayee Biotechnology | 96T | EUR 420 |
genesig Easy kit for Strongylus vulgaris |
|||
Z-Path-S.vulgaris-EASY | Novacyt Group | 50 tests | EUR 410 |
Description: S.vulgaris |
Strongyloides IgG/IgM |
|||
DESTRO0690 | Demeditec Diagnostics | 96 | EUR 134 |
Strongzyme Goat anti Mouse IgG (H+L) (HRP) |
|||
43R-1653 | Fitzgerald | 1 ml | EUR 763.2 |
Description: Strongzyme Goat anti-Mouse IgG (H+L) secondary antibody (HRP) |
Strongzyme Rabbit anti Goat IgG (H+L) (HRP) |
|||
43R-1650 | Fitzgerald | 1 ml | EUR 813 |
Description: Strongzyme Rabbit anti Goat IgG (H + L) (HRP) secondary antibody |
Strongzyme Goat anti Rabbit IgG (H + L) (HRP) |
|||
43R-1652 | Fitzgerald | 1 ml | EUR 648 |
Description: Strongzyme Goat anti Rabbit IgG (H + L) secondary antibody (HRP) |
QPCR Kit DNA Strongylus vulgaris |
|||
MOL8942 | Scientific Laboratory Supplies | EACH | EUR 987.17 |
Human Strongyloides IgG Elisa Kit |
|||
EK713927 | AFG Bioscience LLC | 96 Wells | EUR 0.4 |
QPCR Kit DNA Strongylus vulgaris - EACH |
|||
MOL8940 | Scientific Laboratory Supplies | EACH | EUR 1129.51 |
genesig Real-time PCR detection kit for Strongylus vulgaris |
|||
Z-Path-S-vulgaris | Novacyt Group | 150 tests | EUR 808 |
Description: S.vulgaris |
genesig Std Real-time PCR detection kit, Strongylus vulgaris |
|||
Z-Path-S-vulgaris-std | Novacyt Group | 150 tests | EUR 602 |
Description: S.vulgaris |
Strongyloides (IgG/IgM) ELISA Kit (Human) (OKNA00174) |
|||
OKNA00174 | Aviva Systems Biology | 96 Wells | EUR 505.2 |
Description: Description of target: Strongyloides is a genus containing some 50 species of obligate gastrointestinal parasites of vertebrates. Strongyloides stercoralis is the scientific name of a human parasitic roundworm causing the disease of strongyloidiasis. Its common name is pinworm in the UK and threadworm in the US. The Strongyloides stercoralis nematode can parasitize humans. The adult parasitic stage lives in tunnels in the mucosa of the small intestine.S. stercoralis can be found in areas with tropical and subtropical climates but cases also occur in temperate area, more frequently in rural areas. S. stercoralis has a very low prevalence in societies where fecal contamination of soil or water is rare. Many people infected are usually asymptomatic at first. Symptoms include dermatitis: swelling, itching, larva currens, and mild hemorrhage at the site where the skin has been penetrated. If the parasite reaches the lungs, the chest may feel as if it is burning, and wheezing and coughing may result, along with pneumonia-like symptoms (Löffler's syndrome). The intestines could eventually be invaded, leading to burning pain, tissue damage, sepsis, and ulcers. In severe cases, edema may result in obstruction of the intestinal tract, as well as loss of peristaltic contractions. Strongyloides infection in immunocompromised individuals (particularly following the administration of steroids, for example following transplant surgery) can result in disseminated strongyloidiasis, in which worms move beyond the confines of the gut into other organs. This is fatal unless antiStrongyloides therapy is given.Locating juvenile larvae, either rhabditiform or filariform, in recent stool samples will confirm the presence of this parasite. Other techniques used include direct fecal smears, culturing fecal samples on agar plates, serodiagnosis through ELISA, and duodenal fumigation.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Reverse Capture Sandwich ELISA ;Sensitivity: Sensitivity is determined as the probability of the assay indicating a positive score in samples with the specific analyte present: 87.9% |
StrongZyme Streptavidin-PolyHRP (High Load) |
|||
43R-1645 | Fitzgerald | 1 mg | EUR 380 |
Description: StrongZyme Streptavidin-PolyHRP conjugate (High Load) |
Fscn1 (GFP-tagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1) |
|||
MG207918 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn1 (untagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1), (10ug) |
|||
MC216780 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN1 (GFP-tagged) - Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1) |
|||
RG203031 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN1 (untagged)-Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1) |
|||
SC118222 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn1 (Myc-DDK-tagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1) |
|||
MR207918 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN1 (untagged)-Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1) |
|||
SC320744 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn2 (untagged) - Mouse fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), (10ug) |
|||
MC216896 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn3 (untagged ORF) - Rat fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), (10 ug) |
|||
RN201308 | Origene Technologies GmbH | 10 µg | Ask for price |
Rabbit polyclonal antibody to Fascin (fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus)) |
|||
TA308801 | Origene Technologies GmbH | 100 µl | Ask for price |
FSCN1 (Myc-DDK-tagged)-Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1) |
|||
RC203031 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), mGFP tagged |
|||
RC203031L2 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), mGFP tagged |
|||
RC203031L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn1 (mGFP-tagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1) |
|||
MR207918L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn2 (untagged ORF) - Rat fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), (10 ug) |
|||
RN206219 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn3 (GFP-tagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3) |
|||
MG207995 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn3 (untagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), (10ug) |
|||
MC216995 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN3 (GFP-tagged) - Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3) |
|||
RG207492 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn2 (Myc-DDK-tagged ORF) - Rat fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), (10 ug) |
|||
RR206219 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn3 (Myc-DDK-tagged ORF) - Rat fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), (10 ug) |
|||
RR201308 | Origene Technologies GmbH | 10 µg | Ask for price |
3`UTR clone of fascin homolog 1 actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1) for miRNA target validation |
|||
SC213307 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN3 (untagged)-Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3) |
|||
SC323970 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), Myc-DDK-tagged |
|||
RC203031L1 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), Myc-DDK-tagged |
|||
RC203031L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn2 (Myc-DDK-tagged) - Mouse fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2) |
|||
MR225952 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn1 (Myc-DDK-tagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1) |
|||
MR207918L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn2 (GFP-tagged) - Mouse fascin homolog 2 actin-bundling protein retinal (Strongylocentrotus purpuratus) (Fscn2), (10ug) |
|||
MG225952 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN3 (Myc-DDK-tagged)-Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3) |
|||
RC207492 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3), mGFP tagged |
|||
RC207492L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn2 (Myc-DDK-tagged ORF) - Rat fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), (1 |
|||
RR206219L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn2 (mGFP-tagged ORF) - Rat fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), (10 u |
|||
RR206219L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, FSCN1 (Myc-DDK tagged) - Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), 200ul, >10^ |
|||
RC203031L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, FSCN1 (mGFP-tagged) - Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), 200ul, >10^7 T |
|||
RC203031L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, FSCN1 (Myc-DDK tagged) - Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), 200ul, >10^ |
|||
RC203031L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, FSCN1 (mGFP-tagged) - Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), 200ul, >10^7 T |
|||
RC203031L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Fscn2 (mGFP-tagged) - Mouse fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2) |
|||
MR225952L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Fscn1 (Myc-DDK-tagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1), 200ul, >10^ |
|||
MR207918L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fscn1 (GFP-tagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1), 200ul, >10^7 TU |
|||
MR207918L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Fscn3 (Myc-DDK-tagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3) |
|||
MR207995 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, FSCN2 (Myc-DDK tagged) - Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), tr |
|||
RC221223L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 1, mGFP ta |
|||
RC221223L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, FSCN2 (Myc-DDK tagged) - Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), tr |
|||
RC221276L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 2, mGFP ta |
|||
RC221276L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3), Myc-DDK-tagged |
|||
RC207492L3 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN2 (GFP-tagged) - Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 1 |
|||
RG221223 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN2 (GFP-tagged) - Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 2 |
|||
RG221276 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Fscn2 (Myc-DDK-tagged ORF) - Rat fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), |
|||
RR206219L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fscn2 (GFP-tagged ORF) - Rat fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), 200u |
|||
RR206219L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Fscn3 (Myc-DDK-tagged ORF) - Rat fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), |
|||
RR201308L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn3 (mGFP-tagged ORF) - Rat fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), (1 |
|||
RR201308L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Fscn3 (GFP-tagged ORF) - Rat fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), 2 |
|||
RR201308L4V | Origene Technologies GmbH | 200 µl | Ask for price |
FSCN2 (untagged)-Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 1 |
|||
SC303980 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn2 (Myc-DDK-tagged) - Mouse fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2) |
|||
MR225952L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Fscn2 (GFP-tagged) - Mouse fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), 200ul, |
|||
MR225952L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Fscn3 (Myc-DDK-tagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3) |
|||
MR207995L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn3 (mGFP-tagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3) |
|||
MR207995L4 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN2 (untagged)-Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 2 |
|||
SC315582 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN2 (Myc-DDK-tagged)-Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 1 |
|||
RC221223 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 1, Myc-DDK |
|||
RC221223L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, FSCN2 (mGFP-tagged) - Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), trans |
|||
RC221223L4V | Origene Technologies GmbH | 200 µl | Ask for price |
FSCN2 (Myc-DDK-tagged)-Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 2 |
|||
RC221276 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 2, Myc-DDK |
|||
RC221276L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, FSCN2 (mGFP-tagged) - Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), trans |
|||
RC221276L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, FSCN3 (Myc-DDK tagged) - Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3), |
|||
RC207492L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, FSCN3 (mGFP-tagged) - Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3), 20 |
|||
RC207492L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fscn3 (Myc-DDK-tagged ORF) - Rat fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3 |
|||
RR201308L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fscn2 (Myc-DDK-tagged) - Mouse fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), 20 |
|||
MR225952L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fscn3 (Myc-DDK-tagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), |
|||
MR207995L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fscn3 (GFP-tagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), 200 |
|||
MR207995L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Human Strontium (Strontium) Elisa Kit |
|||
EK710512 | AFG Bioscience LLC | 96 Wells | EUR 0.98 |
Strontium Oxide |
|||
32315-42 | NACALAI TESQUE | 25G | EUR 61.6 |
Strontium Oxide |
|||
abx186564-500g | Abbexa | 500 g | EUR 309.6 |
Strontium oxide, 99.5% |
|||
GX8751-50 | Glentham Life Sciences | 50 | EUR 585.6 |
Strontium Iodate 99% |
|||
S09620 | Pfaltz & Bauer | 10G | EUR 135 |
Strontium Acetate |
|||
32302-02 | NACALAI TESQUE | 25G | EUR 22.75 |
Strontium acetate |
|||
S09490 | Pfaltz & Bauer | 100G | EUR 216.3 |
Strontium bromide 99% |
|||
S09540 | Pfaltz & Bauer | 100G | EUR 242.2 |
Strontium ferrite 99.5% |
|||
S09575 | Pfaltz & Bauer | 5G | EUR 191.06 |
Strontium formate |
|||
S09590 | Pfaltz & Bauer | 25G | EUR 253.25 |
Strontium hydride 99.5% |
|||
S09600 | Pfaltz & Bauer | 1G | EUR 188.28 |
Strontium lactate |
|||
S09650 | Pfaltz & Bauer | 100G | EUR 1278.7 |
Strontium oxalate |
|||
S09697 | Pfaltz & Bauer | 100G | EUR 99.5 |
Strontium sulfate |
|||
S09810 | Pfaltz & Bauer | 25G | EUR 106.53 |